SCHEMBL28675181

SCHEMBL28675181

CC(C)(C)OC(=O)N1CCc2cc(C(=O)CC(N)O)ccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.46
ALDH1A1 P00352 7/20 0.45
KDM4E B2RXH2 4/20 0.45
HPGD P15428 3/20 0.45
RECQL P46063 1/20 0.45
MAPT P10636 5/20 0.44
HSD17B10 Q99714 1/20 0.44
DHODH Q02127 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MPO P05164 1/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
ABHD6 Q9BV23 1/20 0.40
SRD5A1 P18405 1/20 0.39
NR1H2 P55055 1/20 0.39
KDM1A O60341 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19689701 0.85 ALDH1A1 (0.51) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL19689700 0.81 GPR119 (0.47) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL380505 0.81 DHODH (0.49) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL30527088 0.81 DHODH (0.49) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL21724876 0.80 GPR119 (0.46) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL30681278 0.79 GPR119 (0.45) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL846218 0.79 HDAC1 (0.53) GPR119ALDH1A1KDM4EHPGDMAPT
SCHEMBL19689717 0.78 GPR119 (0.47) GPR119DHODHMPOABHD6NR1H2
SCHEMBL21042103 0.77 GPR119 (0.45) GPR119ALDH1A1KDM4EHPGDRECQL
SCHEMBL19689708 0.77 GPR119 (0.47) GPR119ALDH1A1MAPTDHODHSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641881-B 1-tetrahydropyranyl carbonyl-2, 3-dihydro-1H-indole compounds for use in the treatment of cancer 伊莱利利公司 2022-01-07 CN disclosed